Telomeres Might Predict Lung Cancer Recurrence
Telomeres are sections of DNA that tell an interesting story about lifespan. Shorter telomeres usually suggest a shorter life -- but new research by a Wilmot lung cancer expert shows that longer telomeres might be a promising biomarker for a recurrence of early stage lung cancer.
In a recent study in Nature Immunology, Deborah Fowell, Ph.D., associate professor of Microbiology and Immunology, mapped how immune cells travel to sites of injury or infection. She says the findings could help with the development of treatments that stop, slow down or speed up the immune response. Check out this video of Fowell for more details on her work.
8/21/2013 | 0 comments
Copper is ubiquitous in the food supply and drinking water. In the right amounts, it helps the body perform many important functions. However, a new study points to the metal’s darker side: too much copper can accumulate in the brain and contribute to the buildup of toxic proteins that cause Alzheimer’s disease.
8/19/2013 | 1 comment
Personalized medicine – or matching a patient’s tumor with an appropriate treatment – is transforming lung cancer and bringing a measure of hope to patients, according to a review by Eric S. Kim, M.D., and Kishan J. Pandya, M.D., of the James P. Wilmot Cancer Center, published in the journal Expert Opinion on Medical Diagnostics.
8/15/2013 | 1 comment
Autism expert Susan Hyman, M.D., comments on a new study published in this week’s JAMA Pediatrics that found that children born to mothers who had labor induced or augmented were more likely to develop autism.
8/13/2013 | 0 comments
As part of the National Institutes of Health's Centers of Excellence in Influenza Research and Surveillance (CEIRS), URMC scientists John Treanor, M.D., and David Topham, Ph.D., join their peers in calling for more advanced research on the H7N9 bird flu virus that appeared in China earlier this year. In this video, they describe this research and why it’s important.
8/12/2013 | 0 comments